CS logo
small CS logo
UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"

Barletta, Italy
General hospital in Barletta
Viale Ippocrate, 15, 70051 Barletta BT

About UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Fondazione Italiana Linfomi ONLUS
4
Gruppo Italiano Malattie EMatologiche dell'Adulto
4
Total Rows: 2

Clinical Trials at UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"


During the past decade, UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli" conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years112222000011000000000000Started TrialsCompleted Trails2017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid Leukemia
2012-01-01
2018-07-10
Completed
515
Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients
2013-10-01
2018-05-01
Unknown status
100
FIL Study on ABVD DD-DI as Upfront Therapy in HL.
2017-08-01
2023-01-01
Active, not recruiting
500
Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia
2018-06-08
2024-02-01
Active, not recruiting
149
Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis
2018-08-10
2026-01-01
Recruiting
400
Long-term Outcomes for Acute Myeloid Leukemia Patients
2019-05-16
2022-12-01
Unknown status
343
Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study
2019-10-02
2023-09-21
Active, not recruiting
633
Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
2022-12-01
2028-12-08
Not yet recruiting
140

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsFondazione ItalianaLinfomi ONLUS: 4Fondazione ItalianaLinfomi ONLUS: 4Gruppo Italiano MalattieEMatologichedell'Adulto: 4Gruppo Italiano MalattieEMatologichedell'Adulto: 4

Created with Highcharts 11.1.0Top CollaboratorsEuropean Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1Roche Pharma AG: 1Roche Pharma AG: 1

Clinical Trials Conditions at UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"


According to Clinical.Site data, the most researched conditions in "UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"" are "Acute Myeloid Leukemia" (2 trials), "Acute Lymphoid Leukemia" (1 trials), "B-cell" (1 trials), "CLL" (1 trials) and "Classical Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"" in a lesser frequency.

Clinical Trials Intervention Types at UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"


Most popular intervention types in "UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"" are "Drug" (3 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "BEGEV" (1 trials), "Bleomycin" (1 trials), "Chemotherapy + Blinatumomab" (1 trials) and "Dacarbazine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"


The vast majority of trials in "UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"" are 8 trials for "All" genders.

Clinical Trials Status at UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"


Currently, there are NaN active trials in "UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"". 1 are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli", undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli", 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 3Phase 2: 3Phase 1: 1Phase 1: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 3Active, not recruiting: 3Unknown status: 2Unknown status: 2Completed: 1Completed: 1Not yet recruiting: 1Not yet recruiting: 1Recruiting: 1Recruiting: 1